Business Description
INVO Fertility Inc
NAICS : 339113
SIC : 5047
ISIN : US44984F7087
Total Employee Number:
46Description
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.23 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -6.23 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 91.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 56.27 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.64 | |||||
9-Day RSI | 35.74 | |||||
14-Day RSI | 39.42 | |||||
3-1 Month Momentum % | -29.85 | |||||
6-1 Month Momentum % | -66.91 | |||||
12-1 Month Momentum % | -98.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 17.16 | |||||
Days Sales Outstanding | 11.68 | |||||
Days Payable | 210.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 115.37 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.9 | |||||
Operating Margin % | -86.31 | |||||
Net Margin % | -158.73 | |||||
EBITDA Margin % | -107.67 | |||||
FCF Margin % | -75.02 | |||||
OCF Margin % | -74.62 | |||||
ROE % | -168.2 | |||||
ROA % | -49.92 | |||||
ROIC % | -24.39 | |||||
3-Year ROIIC % | 29.52 | |||||
ROC (Joel Greenblatt) % | -351.57 | |||||
ROCE % | -72.49 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.12 | |||||
Price-to-Tangible-Book | 0.27 | |||||
EV-to-EBIT | -0.18 | |||||
EV-to-EBITDA | -0.19 | |||||
EV-to-Revenue | 0.21 | |||||
EV-to-Forward-Revenue | 0.6 | |||||
EV-to-FCF | -0.28 | |||||
Price-to-GF-Value | 0.01 | |||||
Earnings Yield (Greenblatt) % | -555.56 | |||||
FCF Yield % | -268.38 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
INVO Fertility Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.219 | ||
| EPS (TTM) ($) | -1629.755 | ||
| Beta | 2.1584 | ||
| 3-Year Sharpe Ratio | -1.41 | ||
| 3-Year Sortino Ratio | -1.59 | ||
| Volatility % | 131.49 | ||
| 14-Day RSI | 39.42 | ||
| 14-Day ATR ($) | 0.282726 | ||
| 20-Day SMA ($) | 1.521 | ||
| 12-1 Month Momentum % | -98.57 | ||
| 52-Week Range ($) | 1.13 - 169.6 | ||
| Shares Outstanding (Mil) | 1.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
INVO Fertility Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
INVO Fertility Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-17 | In 129 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 34 days | ||
| General meeting for 2026 | 2026-07-23 12:00 | In 13 days | ||
| First quarter earnings results for 2026 | 2026-06-22 | 1.50 (-3.23%) | ||
| Annual report for 2025 | 2026-06-02 | 1.47 (-17.18%) | ||
| Fourth quarter earnings results for 2025 | 2026-06-02 | 1.47 (-17.18%) | ||
| 0.2:1 Stock Split | 2026-03-27 | 2.89 (-5.80%) | ||
| Guidance call for 2026 | 2026-01-15 15:00 | 4.05 (-2.41%) | ||
| 0.125:1 Stock Split | 2025-11-28 | 10.12 (+3.22%) | ||
| Third quarter earnings results for 2025 | 2025-11-17 | 19.30 (-0.32%) |
Show
Entries
INVO Fertility Inc Frequently Asked Questions
What is INVO Fertility Inc(IVF)'s stock price today?
The current price of IVF is $1.13. The 52 week high of IVF is $169.60 and 52 week low is $1.13.
When is next earnings date of INVO Fertility Inc(IVF)?
The next earnings date of INVO Fertility Inc(IVF) is 2026-08-14 Est..
Does INVO Fertility Inc(IVF) pay dividends? If so, how much?
INVO Fertility Inc(IVF) does not pay dividend.
Guru Commentaries on NAS:IVF
No articles.
Press Release
Articles on INVO Fertility Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers